{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:31:52Z","timestamp":1759336312138},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Studies focusing on patterns of psychotropic drug prescriptions (PDPs) for subpopulations of community-dwelling older people with dementia are lacking.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>The aim of this study was to identify the longitudinal patterns of PDPs in subpopulations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective study used electronic health records from general practitioners (GPs) in the Netherlands. People (<jats:italic>N<\/jats:italic>\u2009=\u20091278) firstly diagnosed with dementia between 2013 and 2015, aged 65\u00a0years or older, were selected and categorized into four subpopulations: community-dwelling (CD) group throughout follow-up, ultimately admitted to nursing homes (NH) group, ultimately died (DIE) group, and ultimately deregistered for unclear reasons (DeR) group. Generalised estimating equations were used to estimate the patterns of psychotropic drug prescriptions, after the diagnosis of dementia for a five-year follow-up, and 0\u20133\u00a0months before institutionalisation or death.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Over the five-year follow-up, antipsychotic prescriptions increased steadily in CD (OR\u2009=\u20091.07 [1.04\u20131.10]), NH (OR\u2009=\u20091.10 [1.04\u20131.15]), and DIE (OR\u2009=\u20091.05 [1.02\u20131.08]) groups. Similarly, prescriptions of antidepressants also showed upward trends in CD (OR\u2009=\u20091.04 [1.02\u20131.06]), NH (OR\u2009=\u20091.10 [1.02\u20131.18]), and DIE (OR\u2009=\u20091.04 [1.00\u20131.08]) groups. The other psychotropic drugs did not show clear changes over time in most of the subpopulations. In the three months before institutionalisation, antipsychotic prescriptions increased (OR\u2009=\u20092.12 [1.26\u20133.57]) in the NH group compared to prior periods. Likewise, before death, prescriptions of antipsychotics (OR\u2009=\u20091.74 [1.28\u20132.38]) and hypnotics and sedatives (OR\u2009=\u20092.11 [1.54\u20132.90]) increased in the DIE group, while anti-dementia drug prescriptions decreased (OR\u2009=\u20090.42 [0.26\u20130.69]).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>After community-dwelling older people are diagnosed with dementia, all subpopulations\u2019 prescriptions of antipsychotics and antidepressants increase continuously during the follow-up. While we cannot judge whether these prescriptions are appropriate, GPs might consider a more reluctant use of psychotropic drugs and use alternative psychosocial interventions. Additionally, antipsychotic prescriptions rise considerably shortly before institutionalisation or death, which might reflect that older people experience more neuropsychiatric symptoms during this period.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12875-023-02021-9","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T04:11:44Z","timestamp":1678680704000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The longitudinal patterns of psychotropic drug prescriptions for subpopulations of community-dwelling older people with dementia: electronic health records based retrospective study"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiamin","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah I. M.","family":"Janus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sytse U.","family":"Zuidema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"2021_CR1","unstructured":"Alzheimer Netherlands. Factsheet figures and facts about dementia. Updated February, 2021. https:\/\/www.alzheimer-nederland.nl\/factsheet-cijfers-en-feiten-over-dementie. Accessed 3 June\u00a02022.\u00a0"},{"issue":"3","key":"2021_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.healthpol.2016.01.014","volume":"120","author":"JAMH Maarse","year":"2016","unstructured":"Maarse JAMH, Jeurissen PPP. The policy and politics of the 2015 long-term care reform in the Netherlands. Health Policy (New York). 2016;120(3):241\u20135. https:\/\/doi.org\/10.1016\/j.healthpol.2016.01.014.","journal-title":"Health Policy (New York)"},{"issue":"3","key":"2021_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1017\/S1041610214002282","volume":"27","author":"P Borsje","year":"2015","unstructured":"Borsje P, Wetzels RB, Lucassen PL, Pot AM, Koopmans RT. The course of neuropsychiatric symptoms in community-dwelling patients with dementia: a systematic review. Int Psychogeriatrics. 2015;27(3):385\u2013405. https:\/\/doi.org\/10.1017\/S1041610214002282.","journal-title":"Int Psychogeriatrics"},{"issue":"1","key":"2021_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/fampra\/cmx061","volume":"35","author":"P Borsje","year":"2018","unstructured":"Borsje P, Lucassen PLBJ, Wetzels RB, Pot AM, Koopmans RTCM. Neuropsychiatric symptoms and psychotropic drug use in patients with dementia in general practices. Fam Pract. 2018;35(1):22\u20138. https:\/\/doi.org\/10.1093\/fampra\/cmx061.","journal-title":"Fam Pract"},{"issue":"9","key":"2021_CR5","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/gps.4965","volume":"34","author":"AT Isik","year":"2019","unstructured":"Isik AT, Soysal P, Solmi M, Veronese N. Bidirectional relationship between caregiver burden and neuropsychiatric symptoms in patients with Alzheimer\u2019s disease: a narrative review. Int J Geriatr Psychiatry. 2019;34(9):1326\u201334. https:\/\/doi.org\/10.1002\/gps.4965.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"2021_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3233\/JAD-170679","volume":"62","author":"T Backhouse","year":"2018","unstructured":"Backhouse T, Camino J, Mioshi E. What do we know about behavioral crises in dementia? A Systematic Review J Alzheimers Dis. 2018;62(1):99\u2013113. https:\/\/doi.org\/10.3233\/JAD-170679.","journal-title":"A Systematic Review J Alzheimers Dis"},{"issue":"1","key":"2021_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/J.ARR.2011.07.002","volume":"11","author":"M Azermai","year":"2012","unstructured":"Azermai M, Petrovic M, Elseviers MM, Bourgeois J, Van Bortel LM, Vander Stichele RH. Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms. Ageing Res Rev. 2012;11(1):78\u201386. https:\/\/doi.org\/10.1016\/J.ARR.2011.07.002.","journal-title":"Ageing Res Rev"},{"issue":"10248","key":"2021_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413\u201346. https:\/\/doi.org\/10.1016\/S0140-6736(20)30367-6.","journal-title":"Lancet"},{"issue":"3","key":"2021_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1017\/S1041610217002344","volume":"30","author":"SM Dyer","year":"2018","unstructured":"Dyer SM, Harrison SL, Laver K, Whitehead C, Crotty M. An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia. Int psychogeriatrics. 2018;30(3):295\u2013309. https:\/\/doi.org\/10.1017\/S1041610217002344.","journal-title":"Int psychogeriatrics"},{"key":"2021_CR10","unstructured":"NHG working group. NHG-Standaard Dementie (M21). Updated April, 2020.\u00a0https:\/\/richtlijnen.nhg.org\/standaarden\/dementie. Accessed 1 July\u00a02022."},{"issue":"5","key":"2021_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/GERONA\/GLW095","volume":"72","author":"YJ Wei","year":"2017","unstructured":"Wei YJ, Simoni-Wastila L, Lucas JA, Brandt N. Fall and fracture risk in nursing home residents with moderate-to-severe behavioral symptoms of Alzheimer\u2019s Disease and related dementias initiating antidepressants or antipsychotics. J Gerontol A Biol Sci Med Sci. 2017;72(5):695\u2013702. https:\/\/doi.org\/10.1093\/GERONA\/GLW095.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10113","key":"2021_CR12","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","volume":"390","author":"G Livingston","year":"2017","unstructured":"Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673\u2013734. https:\/\/doi.org\/10.1016\/S0140-6736(17)31363-6.","journal-title":"Lancet"},{"issue":"3","key":"2021_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/GERONT\/GNT096","volume":"54","author":"CHM Smits","year":"2014","unstructured":"Smits CHM, Van Den Beld HK, Aartsen MJ, Schroots JJF. Aging in the Netherlands: state of the art and science. Gerontologist. 2014;54(3):335\u201343. https:\/\/doi.org\/10.1093\/GERONT\/GNT096.","journal-title":"Gerontologist"},{"issue":"2","key":"2021_CR14","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1093\/GERONT\/GNX042","volume":"58","author":"JW Kerns","year":"2018","unstructured":"Kerns JW, Winter JD, Winter KM, Kerns CC, Etz RS. Caregiver perspectives about using antipsychotics and other medications for symptoms of dementia. Gerontologist. 2018;58(2):e35\u201345. https:\/\/doi.org\/10.1093\/GERONT\/GNX042.","journal-title":"Gerontologist"},{"issue":"9","key":"2021_CR15","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/GPS.4918","volume":"33","author":"AA Jennings","year":"2018","unstructured":"Jennings AA, Foley T, Walsh KA, Coffey A, Browne JP, Bradley CP. General practitioners\u2019 knowledge, attitudes, and experiences of managing behavioural and psychological symptoms of dementia: a mixed-methods systematic review. Int J Geriatr Psychiatry. 2018;33(9):1163\u201376. https:\/\/doi.org\/10.1002\/GPS.4918.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"2021_CR16","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1136\/bmjopen-2012-002080","volume":"3","author":"C Martinez","year":"2013","unstructured":"Martinez C, Jones RW, Rietbrock S. Trends in the prevalence of antipsychotic drug use among patients with Alzheimer\u2019s disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study. BMJ Open. 2013;3(1):2080. https:\/\/doi.org\/10.1136\/bmjopen-2012-002080.","journal-title":"BMJ Open"},{"issue":"11","key":"2021_CR17","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.euroneuro.2018.04.005","volume":"28","author":"K Orsel","year":"2018","unstructured":"Orsel K, Taipale H, Tolppanen AM, et al. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer\u2019s disease. Eur Neuropsychopharmacol. 2018;28(11):1260\u20139. https:\/\/doi.org\/10.1016\/j.euroneuro.2018.04.005.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"2021_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/gps.5442","volume":"36","author":"KJ Joling","year":"2021","unstructured":"Joling KJ, ten Koppel M, van Hout HPJ, et al. Psychotropic drug prescription rates in primary care for people with dementia from recorded diagnosis onwards. Int J Geriatr Psychiatry. 2021;36(3):443\u201351. https:\/\/doi.org\/10.1002\/gps.5442.","journal-title":"Int J Geriatr Psychiatry"},{"key":"2021_CR19","unstructured":"Factsheet AHON-Database. Updated April, 2021.\u00a0https:\/\/huisartsgeneeskunde-umcg.nl\/system\/files\/factsheet_ahon-database_information_for_researchers.pdf. Accessed 3 June\u00a02022."},{"issue":"1","key":"2021_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3109\/02813438609013970","volume":"4","author":"BG Bentsen","year":"1986","unstructured":"Bentsen BG. International classification of primary care. Scand J Prim Health Care. 1986;4(1):43\u201350. https:\/\/doi.org\/10.3109\/02813438609013970.","journal-title":"Scand J Prim Health Care"},{"key":"2021_CR21","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment, 2022. Oslo, 2021.\u00a0https:\/\/www.whocc.no\/atc_ddd_index_and_guidelines\/guidelines\/. Accessed 31 May\u00a02022."},{"key":"2021_CR22","unstructured":"Zuidema SU, Smalbrugge M, Bil WME, Geelen R, Kok RM, Luijendijk HJ, van der Stelt I, van Strien AM, Vink MT, Vreeken HL. Multidisciplinary Guideline problem behaviour in dementia. Verenso, NIP. Utrecht 2018."},{"issue":"1","key":"2021_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3233\/JAD-131850","volume":"40","author":"H Brodaty","year":"2014","unstructured":"Brodaty H, Connors MH, Xu J, Woodward M, Ames D. Predictors of institutionalization in dementia: a three year longitudinal study. J Alzheimer\u2019s Dis. 2014;40(1):221\u20136. https:\/\/doi.org\/10.3233\/JAD-131850.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"12","key":"2021_CR24","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1093\/gerona\/glz045","volume":"74","author":"RE Kheirbek","year":"2019","unstructured":"Kheirbek RE, Fokar A, Little JT, et al. Association between antipsychotics and all-cause mortality among community-dwelling older adults. Journals Gerontol - Ser A Biol Sci Med Sci. 2019;74(12):1916\u201321. https:\/\/doi.org\/10.1093\/gerona\/glz045.","journal-title":"Journals Gerontol - Ser A Biol Sci Med Sci"},{"issue":"3","key":"2021_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jamda.2018.12.019","volume":"20","author":"E Schwertner","year":"2019","unstructured":"Schwertner E, Secnik J, Garcia-Ptacek S, et al. Antipsychotic treatment associated with increased mortality risk in patients with dementia. a registry-based observational cohort study. J Am Med Dir Assoc. 2019;20(3):323\u20139.","journal-title":"J Am Med Dir Assoc"},{"issue":"10","key":"2021_CR26","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1093\/gerona\/glx239","volume":"73","author":"M Nerius","year":"2018","unstructured":"Nerius M, Johnell K, Garcia-Ptacek S, Eriksdotter M, Haenisch B, Doblhammer G. The Impact of antipsychotic drugs on long-term care, nursing home admission, and death in dementia patients. Journals Gerontol - Ser A Biol Sci Med Sci. 2018;73(10):1396\u2013402. https:\/\/doi.org\/10.1093\/gerona\/glx239.","journal-title":"Journals Gerontol - Ser A Biol Sci Med Sci"},{"issue":"1","key":"2021_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3233\/JAD-170339","volume":"61","author":"D Addesi","year":"2018","unstructured":"Addesi D, Maio R, Smirne N, et al. Prevalence of delirium in a population of elderly outpatients with dementia: a retrospective study. J Alzheimer\u2019s Dis. 2018;61(1):251\u20137. https:\/\/doi.org\/10.3233\/JAD-170339.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"10","key":"2021_CR28","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1007\/s40520-021-01806-1","volume":"33","author":"L Tremolizzo","year":"2021","unstructured":"Tremolizzo L, Bargossi L, Storti B, Ferrarese C, Bellelli G, Appollonio I. Delirium in your house: a survey during General Practitioner-programmed home visits. Aging Clin Exp Res. 2021;33(10):2747\u201351. https:\/\/doi.org\/10.1007\/s40520-021-01806-1.","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"2021_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s41999-019-00261-6","volume":"11","author":"A Morandi","year":"2020","unstructured":"Morandi A, Bellelli G. Delirium superimposed on dementia. Eur Geriatr Med. 2020;11(1):53\u201362. https:\/\/doi.org\/10.1007\/s41999-019-00261-6.","journal-title":"Eur Geriatr Med"},{"key":"2021_CR30","doi-asserted-by":"publisher","first-page":"205031211666187","DOI":"10.1177\/2050312116661877","volume":"4","author":"CN Porter","year":"2016","unstructured":"Porter CN, Miller MC, Lane M, Cornman C, Sarsour K, Kahle-Wrobleski K. The influence of caregivers and behavioral and psychological symptoms on nursing home placement of persons with Alzheimer\u2019s disease: a matched case\u2013control study. SAGE Open Med. 2016;4:205031211666187. https:\/\/doi.org\/10.1177\/2050312116661877.","journal-title":"SAGE Open Med"},{"issue":"10","key":"2021_CR31","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.jamda.2019.03.027","volume":"20","author":"M Dufournet","year":"2019","unstructured":"Dufournet M, Dauphinot V, Moutet C, et al. Impact of cognitive, functional, behavioral disorders, and caregiver burden on the risk of nursing home placement. J Am Med Dir Assoc. 2019;20(10):1254\u201362. https:\/\/doi.org\/10.1016\/j.jamda.2019.03.027.","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"2021_CR32","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1001\/jamapsychiatry.2014.3018","volume":"72","author":"DT Maust","year":"2015","unstructured":"Maust DT, Kim HM, Seyfried LS, et al. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiat. 2015;72(5):438\u201345. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.3018.","journal-title":"JAMA Psychiat"},{"issue":"10","key":"2021_CR33","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/gps.2225","volume":"24","author":"SU Zuidema","year":"2009","unstructured":"Zuidema SU, De Jonghe JFM, Verhey FRJ, Koopmans RTCM. Predictors of neuropsychiatric symptoms in nursing home patients: influence of gender and dementia severity. Int J Geriatr Psychiatry. 2009;24(10):1079\u201386. https:\/\/doi.org\/10.1002\/gps.2225.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"12","key":"2021_CR34","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1111\/j.1532-5415.2005.00535.x","volume":"53","author":"R Holtzer","year":"2005","unstructured":"Holtzer R, Scarmeas N, Wegesin DJ, et al. Depressive symptoms in Alzheimer\u2019s disease: natural course and temporal relation to function and cognitive status. J Am Geriatr Soc. 2005;53(12):2083\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.00535.x.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"2021_CR35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/0269216313493685","volume":"28","author":"JT Van Der Steen","year":"2014","unstructured":"Van Der Steen JT, Radbruch L, Hertogh CM, et al. White paper defining optimal palliative care in older people with dementia: a Delphi study and recommendations from the European association for palliative care. Palliat Med. 2014;28(3):197\u2013209. https:\/\/doi.org\/10.1177\/0269216313493685.","journal-title":"Palliat Med"},{"issue":"7","key":"2021_CR36","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/j.1532-5415.2008.01741.x","volume":"56","author":"HM Holmes","year":"2008","unstructured":"Holmes HM, Sachs GA, Shega JW, Hougham GW, Cox Hayley D, Dale W. Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. J Am Geriatr Soc. 2008;56(7):1306\u201311. https:\/\/doi.org\/10.1111\/j.1532-5415.2008.01741.x.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"2021_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/0269881116680924","volume":"31","author":"JT O\u2019Brien","year":"2017","unstructured":"O\u2019Brien JT, Holmes C, Jones M, et al. Clinical practice with anti-dementia drugs: a revised (third) consensus statement from the British association for psychopharmacology. J Psychopharmacol. 2017;31(2):147\u201368. https:\/\/doi.org\/10.1177\/0269881116680924.","journal-title":"J Psychopharmacol"},{"issue":"4","key":"2021_CR38","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/pds.4921","volume":"29","author":"M Fran\u00e7ois","year":"2020","unstructured":"Fran\u00e7ois M, Sicsic J, Pelletier-Fleury N. Determinants of antidementia drug prescription in patients older than 65: a latent class analysis. Pharmacoepidemiol Drug Saf. 2020;29(4):444\u201352. https:\/\/doi.org\/10.1002\/pds.4921.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-023-02021-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-023-02021-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-023-02021-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T04:12:22Z","timestamp":1678680742000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-023-02021-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2021"],"URL":"https:\/\/doi.org\/10.1186\/s12875-023-02021-9","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"13 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study methods were carried out in accordance with the Declaration of Helsinki and other relevant regulations and guidelines. This observational study used anonymized electronic health data from the AHON database. The data cannot be traced back to individual natural persons. In line with Dutch legislation (Dutch Civil Law, Article 7:458), ethics approval and informed consent are not deemed obligatory by the Medical Ethics Review Board of the University Medical Centre Groningen for studies using data from the AHON database (research registration number of the AHON database 202100077).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors report any conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}